This document summarizes immunohistochemistry (IHC) techniques. IHC combines immunological and histological methods to identify specific proteins in tissues using antigen-antibody reactions. The document discusses common IHC methods like direct, indirect, and enzyme-linked methods. It also covers important considerations for IHC like antibody selection, tissue fixation and processing, antigen retrieval, blocking, and controls. The goal of IHC is to visualize the distribution and localization of cellular components, but the quality of results depends highly on proper sample preparation.
Immunohistochemistry (IHC) is the localization of a known antigen in tissues by utilizing antibodies directed towards that (specific) antigen. In this presentation, we will introduce the procedure of IHC and the troubleshooting solutions.
Immunohistochemistry (IHC) is a highly sensitive method that allows the localization of antigen within a cell or a tissue with high resolution. The method is based on the use of a primary antibody that specifically binds to its complementary antigen. The bound antibody may then be visualized by a variety of methods such as colorimetric end points.
Immunohistochemistry (IHC) is the localization of a known antigen in tissues by utilizing antibodies directed towards that (specific) antigen. In this presentation, we will introduce the procedure of IHC and the troubleshooting solutions.
Immunohistochemistry (IHC) is a highly sensitive method that allows the localization of antigen within a cell or a tissue with high resolution. The method is based on the use of a primary antibody that specifically binds to its complementary antigen. The bound antibody may then be visualized by a variety of methods such as colorimetric end points.
This is a presentation I prepared to demonstrate my mastery of the basics of Immunohistochemistry during my first two months of employment as a Biologist at the Cell Marque Corporation. Please note, there are a few slides that appear to be dysfunctional and overlapping; this is due to the fact that these particular slides included complex animations that I designed to illustrate various scientific concepts related to the practice of Immunohistochemistry. If you wish to view this presentation in its entirety (animations included), feel free to contact me via LinkedIn and I will gladly provide you with a fully-functional version.
Introduction, the principle of immunofluorescence, Technique, Fluorescent microscope and its components, Application and types of immunofluorescence, Direct and indirect immunofluorescence, FACS (Fluorescence-activated cell sorting), Uses and limitations of Immunofluorescence
cytology of urine tract - this slide contains the specimen collection method, preparation of specimen, types of fixatives, other preparation techniques, urinary tract histology, normal urinary tract cytology,
Basics of immunohistochemistry, steps of histochemistry, primary and secondary antibody use as protein locator and different fixatives with their advantages
This is a presentation I prepared to demonstrate my mastery of the basics of Immunohistochemistry during my first two months of employment as a Biologist at the Cell Marque Corporation. Please note, there are a few slides that appear to be dysfunctional and overlapping; this is due to the fact that these particular slides included complex animations that I designed to illustrate various scientific concepts related to the practice of Immunohistochemistry. If you wish to view this presentation in its entirety (animations included), feel free to contact me via LinkedIn and I will gladly provide you with a fully-functional version.
Introduction, the principle of immunofluorescence, Technique, Fluorescent microscope and its components, Application and types of immunofluorescence, Direct and indirect immunofluorescence, FACS (Fluorescence-activated cell sorting), Uses and limitations of Immunofluorescence
cytology of urine tract - this slide contains the specimen collection method, preparation of specimen, types of fixatives, other preparation techniques, urinary tract histology, normal urinary tract cytology,
Basics of immunohistochemistry, steps of histochemistry, primary and secondary antibody use as protein locator and different fixatives with their advantages
Immunohistochemistry (IHC) is the process of detecting antigens (e.g. proteins) in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues.
https://www.creative-bioarray.com/protocol/immunohistochemistry-protocol.htm
OTECHNOLOGY IS CHALLENGING SUBJECT TO TEACH AND UNDERSTAND ALSO .....THEIR INTERESTING PART IS TO LEARN ABOUT MICROBIAL GENETICS AND THEIR METHODS OF GENE TRANSFER
Antibody Based Techniques Masterclass by ProteintechProteintech Group
Tips to optimize your antibody based lab techniques, covering common antibody applications including Western blot, Immunohistochemistry (IHC), Immunoprecipotation (IP) and Immunofluorescence (IF).
Proteintech technical workshops are coordinated by Dr Szczesna (Proteintech's technical expert) and cover a range of topics including step-by-step protocol optimization, FAQS and troubleshooting tips.
Immunohistochemistry is one of the most advance techniques in immuno-staining. In this presentation is a brief introduction to what is IHC, the principle, procedure and applications.
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
UiPath Test Automation using UiPath Test Suite series, part 3DianaGray10
Welcome to UiPath Test Automation using UiPath Test Suite series part 3. In this session, we will cover desktop automation along with UI automation.
Topics covered:
UI automation Introduction,
UI automation Sample
Desktop automation flow
Pradeep Chinnala, Senior Consultant Automation Developer @WonderBotz and UiPath MVP
Deepak Rai, Automation Practice Lead, Boundaryless Group and UiPath MVP
LF Energy Webinar: Electrical Grid Modelling and Simulation Through PowSyBl -...DanBrown980551
Do you want to learn how to model and simulate an electrical network from scratch in under an hour?
Then welcome to this PowSyBl workshop, hosted by Rte, the French Transmission System Operator (TSO)!
During the webinar, you will discover the PowSyBl ecosystem as well as handle and study an electrical network through an interactive Python notebook.
PowSyBl is an open source project hosted by LF Energy, which offers a comprehensive set of features for electrical grid modelling and simulation. Among other advanced features, PowSyBl provides:
- A fully editable and extendable library for grid component modelling;
- Visualization tools to display your network;
- Grid simulation tools, such as power flows, security analyses (with or without remedial actions) and sensitivity analyses;
The framework is mostly written in Java, with a Python binding so that Python developers can access PowSyBl functionalities as well.
What you will learn during the webinar:
- For beginners: discover PowSyBl's functionalities through a quick general presentation and the notebook, without needing any expert coding skills;
- For advanced developers: master the skills to efficiently apply PowSyBl functionalities to your real-world scenarios.
"Impact of front-end architecture on development cost", Viktor TurskyiFwdays
I have heard many times that architecture is not important for the front-end. Also, many times I have seen how developers implement features on the front-end just following the standard rules for a framework and think that this is enough to successfully launch the project, and then the project fails. How to prevent this and what approach to choose? I have launched dozens of complex projects and during the talk we will analyze which approaches have worked for me and which have not.
GDG Cloud Southlake #33: Boule & Rebala: Effective AppSec in SDLC using Deplo...James Anderson
Effective Application Security in Software Delivery lifecycle using Deployment Firewall and DBOM
The modern software delivery process (or the CI/CD process) includes many tools, distributed teams, open-source code, and cloud platforms. Constant focus on speed to release software to market, along with the traditional slow and manual security checks has caused gaps in continuous security as an important piece in the software supply chain. Today organizations feel more susceptible to external and internal cyber threats due to the vast attack surface in their applications supply chain and the lack of end-to-end governance and risk management.
The software team must secure its software delivery process to avoid vulnerability and security breaches. This needs to be achieved with existing tool chains and without extensive rework of the delivery processes. This talk will present strategies and techniques for providing visibility into the true risk of the existing vulnerabilities, preventing the introduction of security issues in the software, resolving vulnerabilities in production environments quickly, and capturing the deployment bill of materials (DBOM).
Speakers:
Bob Boule
Robert Boule is a technology enthusiast with PASSION for technology and making things work along with a knack for helping others understand how things work. He comes with around 20 years of solution engineering experience in application security, software continuous delivery, and SaaS platforms. He is known for his dynamic presentations in CI/CD and application security integrated in software delivery lifecycle.
Gopinath Rebala
Gopinath Rebala is the CTO of OpsMx, where he has overall responsibility for the machine learning and data processing architectures for Secure Software Delivery. Gopi also has a strong connection with our customers, leading design and architecture for strategic implementations. Gopi is a frequent speaker and well-known leader in continuous delivery and integrating security into software delivery.
Smart TV Buyer Insights Survey 2024 by 91mobiles.pdf91mobiles
91mobiles recently conducted a Smart TV Buyer Insights Survey in which we asked over 3,000 respondents about the TV they own, aspects they look at on a new TV, and their TV buying preferences.
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
Kubernetes & AI - Beauty and the Beast !?! @KCD Istanbul 2024Tobias Schneck
As AI technology is pushing into IT I was wondering myself, as an “infrastructure container kubernetes guy”, how get this fancy AI technology get managed from an infrastructure operational view? Is it possible to apply our lovely cloud native principals as well? What benefit’s both technologies could bring to each other?
Let me take this questions and provide you a short journey through existing deployment models and use cases for AI software. On practical examples, we discuss what cloud/on-premise strategy we may need for applying it to our own infrastructure to get it to work from an enterprise perspective. I want to give an overview about infrastructure requirements and technologies, what could be beneficial or limiting your AI use cases in an enterprise environment. An interactive Demo will give you some insides, what approaches I got already working for real.
2. Common Methods of protein
detection
ELISA
Gel Electrophoresis
Western blot
Immunoprecipitation
Spectrophotometry
Enzyme assays
X-ray crystallography
NMR
Immunohistochemistry
3. Immunohistochemistry – what’s
good about it?
Antibodies bind to antigen in specific manner
Gives you a spatial location
Can be used to locate particular cells and
proteins
Can be used to identify cellular events –
e.g.apoptosis
4. Introduction
Immunohistochemistry (IHC) combines
histological, immunological and biochemical
techniques for the identification of specific
tissue components by means of a specific
antigen/antibody reaction tagged with a
visible label. IHC makes it possible to visualize
the distribution and localization of specific
cellular components within a cell or tissue.
5. History
The principle has existed since the 1930s.
Started in 1941 when Coons identified pneumococci
using a direct fluorescent method.
Indirect method
Addition of horseradish peroxidase
Peroxidase anti-peroxidase technique in 1979
Use of Avidin & Biotin complex in early 1980’s
13. Important considerations for
IHC
Antibody selection
Fixation
Sectioning
Antigen Retrieval
Blocking
Controls
Direct method
Indirect method
Immunoenzyme
Fluorescence
Multiple labeling
You actually need to care about all this now because it may
affect how you harvest your samples !
14. Options for antibodies that
will affect your results
Monoclonal v. Polyclonal
Raised against whole molecule, N-terminus,
C-terminus, specific amino acids
Ascites, supernatant, serum
16. Monoclonal v. polyclonal
Monoclonal
Mouse or rabbit
hybridoma
Tends to be ‘cleaner’
Very consistent batch-
to-batch
More likely to get false
negative results
Polyclonal
Many different species
Tends to have more
non-specific reactivity
Can have very different
avidity/affinity batch-to-
batch
More likely to have
success in an unknown
application
17. Make sure your antibody is
validated for your
application!!!
IF v. IHC with fluorescence
WB, ELISA, IP, etc.
18. Whole molecule or specific
portion of epitope?
Very dependent on individual assay
20. Fixation
Aldehyde
10% NBF
4% formaldehyde with
PBS buffer
2% formaldehyde with
picric acid and PBS
The paraformaldehyde
paradox
Immersion v. transcardial
perfusion
24-72 hours
Many others
Best for good architecture
Frozen
LN2
With or without sucrose
OCT
Fix with acetone or
methanol (fix by
coagulation, also
permeabilizes)
Best for cell membrane
antigens, cytokines
22. Sectioning
Paraffin
Must heat and process
through xylenes and
alcohols – ruins some
antigens
Most commonly used
BEST if not stored more
than two weeks – lose
antigenicity after that
time
Frozen
Better survival of many
antigens
Poor morphology
Poor resolution at higher
mag
Special storage
Cutting difficulty
23. Antigen retrieval
HIER
Use
MW/steamer/pressure
cooker ~ 20 minutes,
slow cool
Citrate 6.0
Tris-EDTA 9.0
EDTA 8.0
Must determine for each
new antibody/antigen
target
PIER
Proteinase K
Trypsin
Pepsin
Pronase,etc.
Destroys some epitopes
Bad for morphology
24. Improving antibody
penetration
Need this for intracellular (cytoplasmic, nuclear) or
membrane components when epitope is inside cell
membrane
Detergents most popular
Triton-X
Tween
Also decreases surface tension – better coverage
Can’t use for membrane proteins
Acetone/Methanol
Precipitate proteins outside cell membranes- more accessible
Saponin
Punches holes in cell membrane – holes close up when removed
25. Blocking
Background staining
Specific
Polyclonal antibodies – impure antigen used
Inadequate fixation – diffusion of antigen – often
worse in center of large block
Non-specific
Non-immunologic binding – usually uniform
Endogenous peroxidases
Endogenous biotin
27. Controls
Positive control
Best is tissue with known specificity
Negative control
Best is IgG from same species immunized against
non-biologic molecule – e.g. BRDU when no
BRDU is present in tissue
Can also use non-immunized serum from same
species
33. Enzymatic detection methods
Brightfield microscope sufficient for analysisBrightfield microscope sufficient for analysis
of specimensof specimens
Suitable for tissue analysis at lowSuitable for tissue analysis at low
magnificationmagnification
Resolution of subcellular structures not asResolution of subcellular structures not as
good as with fluorescence methods, but cangood as with fluorescence methods, but can
be combined with electron microscopybe combined with electron microscopy
Unimited shelf life of labelled specimensUnimited shelf life of labelled specimens
Substrate reagents often toxic/carcinogenicSubstrate reagents often toxic/carcinogenic
38. Summary
IHC = immunology +histology + chemistry
Has strengths and weaknesses
Think about your planned assay before
acquiring tissue
Good block, appropriately fixed and
sectioned can give you great data
Bad block, inappropriately fixed and
sectioned, can give you misleading data and
waste money
Editor's Notes
The two variable regions recognise bind to antigen (parts of invading bacteria) leading to the invading bacteria being destroyed. Antibodies produced in the body are polyclonal, because each one has a different variable region and can target a different antigen (until a threat is realised in which case they massively overproduce the relavent antibody).The two variable regions recognise bind to antigen (parts of invading bacteria) leading to the invading bacteria being destroyed. Antibodies produced in the body are polyclonal, because each one has a different variable region and can target a different antigen (until a threat is realised in which case they massively overproduce the relavent antibody).
Formaldehyde fixes by formation of hydroxymethyl adducts on reactive side chains of proteins. Once sufficient adducts are formed, they slowly cross-link to stabilize the proteins in a gel-like formation. At room temperature, it takes approximately 24 hours for maximal binding of formaldehyde to occur and hence all the adducts to form. These initial adducts, and any initial cross-links formed, are unstable and easily reversed. For tissues fixed for 24 hours, the cross-links are largely reversed by washing ( in water or 70% EtOH) after a few hours. It probably takes at least 5-7 days for most of the cross-links to form, and a small amount of cross-linking still continues over time. Even after fixation for 7 days or more, the cross-links can still be reversed by prolonged washing. That's great for IHC, since cross-links can be reversed by HIER (which is just washing at elevated temperatures!).
Influence of fixation time, fixation temperature, and trypsin treatment on uPA immunoperoxidase staining of paraffin-embedded specimens of human ductal breast cancer tissue. Specimens were formalin fixed at 4° C for 1 hour (Panels a, f, g), 8 hours (Panel b), and 24 hours (Panel c) or at room temperature for 8 hours (Panel d) and 24 hours (Panel e), and immunostained with polyclonal antibodies to uPA (pAb2, 5 g/ml). Most sections were briefly predigested with trypsin (Panels a–f), although this treatment was omitted for one of the sections (Panel g). Note that when fixation was performed at 4° C, the immunostaining produced is strong in specimens fixed for 1 hour and 8 hours (Panels a, b, f), but barely detectable after fixation for 24 hours (Panel c). At room temperature fixation for 8 hours results in weak staining (Panel d), and fixation for 24 hours results in no immunostaining (Panel e). When trypsin predigestion is omitted, there is little or no uPA immunostaining, even of sections formalin fixed for 1 hour at 4° C (Panel g). Note that the immunostaining in all sections appears in the stroma and not in the cancer cells and that the strongest immunostaining is present in the fibroblast-like cells surrounding the tumor cell islands (arrows in Panel a). Bars in Panels a–e: 30 m; Panels f–g, 50 m